Acta Scientific Ophthalmology (ISSN: 2582-3191)

Short Communication Volume 4 Issue 11

COVID-19 is Not Over Yet - A Personal Experience!

Sunita1 and Faizan Mehmood2*

1Department of Ophthalmology, Vardhman Mahavir Medical College, New Delhi, India
2Bharti Eye Hospital, New Delhi, India

*Corresponding Author: Faizan Mehmood, Bharti Eye Hospital New Delhi, India.

Received: August 27, 2021 ; Published: October 08, 2021


I am an ophthalmologist currently working in New Delhi, India. When India experienced the initial impact of COVID-19, I was working in a Government Hospital in New Delhi. One of my colleagues (a young, energetic person with no comorbidities) working in the same department, unfortunately, tested positive for COVID-19 in October 2020. He developed severe pneumonia with a high-grade fever which needed hospitalization for 14 days. He had post-viral myalgia and weakness for another two weeks and then he finally resumed his duties after a gap of one month to serve the people of the country.



Citation: Sunita and Faizan Mehmood. “COVID-19 is Not Over Yet - A Personal Experience!".Acta Scientific Ophthalmology 4.11 (2021): .


Acceptance rate35%
Acceptance to publication20-30 days
ISI- IF1.042
JCR- IF0.24

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 15, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US